More than 85% of cancer patients developed COVID-19 antibodies after a second dose of Pfizer
After two doses of Pfizer's COVID-19 vaccine, cancer patients are likely to be protected against the virus. In an Israeli study, 86% of patients tested positive for Covid antibodies after two shots.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | COVID-19 | Health | Israel Health | Pfizer | Study | Vaccines